Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.51 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.51 |
| ▸ | AGT | P01019 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30956037 | 1.00 | AGTR1 (0.51) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL8698703 | 0.91 | AGTR1 (0.47) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL9235857 | 0.89 | MEN1 (0.42) | AGTR1AGTR2ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL9025603 | 0.88 | MEN1 (0.41) | AGTR1AGTR2ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL7392888 | 0.88 | AGTR1 (0.43) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL2053236 | 0.87 | AGTR1 (0.44) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL6532773 | 0.87 | AGTR1 (0.46) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL31214399 | 0.87 | AGTR1 (0.42) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL9262004 | 0.86 | AGTR1 (0.46) | AGTR1AGTR2AGTALDH1A1TSHR | |
| SCHEMBL13146764 | 0.86 | AGTR1 (0.55) | AGTR1AGTR2AGTTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108679-A | Preparation method of N- (triphenylmethyl) -5- (4' -methylbiphenyl-2-yl) tetrazole | 南京法恩化学有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-107935957-B | Method for synthesizing high-purity sartan side chain TTBB | 江苏仁明生物科技有限公司 | 2020-08-21 | — | — | CN | claimed |
| EP-3981753-B1 | PREPARATION METHOD FOR TRIPHENYLCHLOROMETHANE | LINHAI HUANAN CHEMICAL CO LTD (CN) | 2026-04-22 | — | — | EP | disclosed |
| US-12091375-B2 | Preparation method for triphenylchloromethane | LINHAI HUANAN CHEMICAL CO., LTD. (CN) | 2024-09-17 | — | — | US | disclosed |
| CN-113748099-B | Preparation method of triphenylchloromethane | 临海市华南化工有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118108679-A | Preparation method of N- (triphenylmethyl) -5- (4' -methylbiphenyl-2-yl) tetrazole | 南京法恩化学有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108679-A | Preparation method of N- (triphenylmethyl) -5- (4' -methylbiphenyl-2-yl) tetrazole | 南京法恩化学有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108679-A | Preparation method of N- (triphenylmethyl) -5- (4' -methylbiphenyl-2-yl) tetrazole | 南京法恩化学有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20220234970-A1 | Preparation Method for Triphenylchloromethane | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD (CN) | 2022-07-28 | — | — | US | disclosed |
| EP-3981753-A1 | PREPARATION METHOD FOR TRIPHENYLCHLOROMETHANE | Linhai Huanan Chemical Co., Ltd. (CN) | 2022-04-13 | — | — | EP | disclosed |
| CN-113748099-A | Preparation method of triphenylchloromethane | 临海市华南化工有限公司 | 2021-12-03 | — | — | CN | disclosed |
| WO-1991000277-A1 | SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | disclosed |
| WO-1991000281-A2 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | disclosed |
| EP-0401030-A2 | Angiotensin II antagonists | MERCK & CO. INC. (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4874867-A | Tetrazole intermediates to antihypertensive compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-10-17 | — | — | US | disclosed |
| US-4870186-A | Tetrazole intermediates to antihypertensive compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-09-26 | — | — | US | disclosed |
| EP-0324377-A2 | Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-07-19 | — | — | EP | disclosed |
| WO-1989006233-A1 | ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES AND COMBINATIONS THEREOF WITH DIURETICS AND NSAIDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-07-13 | — | — | WO | disclosed |
| US-4820843-A | Tetrazole intermediates to antihypertensive compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0291969-A2 | Tetrazole intermediates to antihypertensive compounds | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220234970-A1 | Preparation Method for Triphenylchloromethane | TERT, TST, TLL2 | AGTR1 4564/4885AGTR2 4281/4885AGT 855/4885 |
| US-12091375-B2 | Preparation method for triphenylchloromethane | TERT, TST, TLL2 | AGTR1 4564/4885AGTR2 4281/4885AGT 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.